Ledger.Open graph →
SEC Form D · filed July 15, 2020

Gaiamer Biotechnologies, Inc

Offering
$5.0M
Sold
$100K
Exemption
Rule 506(b)
Industry
Manufacturing
Location
LOS ANGELES, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Jerry Schindler · Acworth, GADirectorCharles Caliman · Los Angeles, CAExec · DirectorAraya Mesfin · Atlanta, GADirectorThomas Trimbach · Los Angeles, CAExec · DirectorJihene Dhaouadi · Long Beach, CADirectorChristopher Sargent · Flushing, MIExec · DirectorKeith Tinsley · Bellflower, CAExec · DirectorBenjamin S. Kaplan · New York, NYExec · DirectorGareth H. Jenkins · New York, NYDirectorAaron L. Kaplan · New York, NYDirectorGrayBul Tyde GP LLC · Greenville, SCDirectorJerry H. Schneider · New York, NYExec · DirectorRosemarie H. Fanelli · New York, NYExec · DirectorRaphael A. Martorello · Denver, COExec · DirectorWilliam B. Morris · Knoxville, TNExec · DirectorPaul Hsu · Dover, DEDirectorAlejandro Zecler · Grand Cayman, Cayman IslandsExec · DirectorMario Ruiz · Emerald Hills, CADirectorNardo N. Manaloto Jr · Pasadena, CAExec · DirectorKelly Cornelis · Chicago, ILDirectorAntti Vuori · VANCOUVER, British Columbia, CanadaExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗